Evidence map›Paper›PMID 33044687›Full record

ArticleAIDS and behavior2021

DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men.

Albert Y Liu, Nicole D Laborde, Kenneth Coleman, Eric Vittinghoff, Rafael Gonzalez, Gretchen Wilde, Annie L Thorne, Ed Ikeguchi, Laura Shafner, Lauren Sunshine and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03387462 (DOT Diary), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03387462 phase4completednot on this map

DOT Diary (D2): Developing a Mobile App With Combined Automated DOT and Daily Sexual Diary for Monitoring and Improving PrEP Adherence: DOT Diary Optimization Pilot

TypeinterventionalSponsorPublic Health Foundation Enterprises, Inc.Ran2018 to 2018Enrolled20ConditionsAdherence, Medication, Risk Behavior, Pre-Exposure Prophylaxis, HIV PreventionArmsEmtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Potential Role of Conversational Agents in Encouraging PrEP Uptake.The journal of behavioral health services & research · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Albert Y LiuBridge HIV, San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 100, San Francisco, CA, 94102, USA. albert.liu@sfdph.org.ORCID http://orcid.org/0000-0003-0320-823X
Nicole D Laborde, San Francisco, USA.
Kenneth ColemanBridge HIV, San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 100, San Francisco, CA, 94102, USA.
Eric VittinghoffDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Rafael GonzalezBridge HIV, San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 100, San Francisco, CA, 94102, USA.
Gretchen WildeDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Annie L ThorneDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Ed IkeguchiAiCure, New York, NY, USA.
Laura ShafnerAiCure, New York, NY, USA.
Lauren SunshineAiCure, New York, NY, USA.
Ariane van der StratenDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Aaron J SieglerDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Susan BuchbinderBridge HIV, San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 100, San Francisco, CA, 94102, USA.

Funding

DOT Diary (D2): Developing a mobile app with combined automated DOT and daily sexual diary for monitoring and improving PrEP adherenceR01MH109320 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI BUCHBINDER, SUSAN · 2015 to 2018
$3.9M
National Institutes of Mental Health R01MH109320NIMH NIH HHS R01 MH109320
6 · The paper itself

Abstract

Young men who have sex with men (YMSM) are highly vulnerable to HIV. While pre-exposure prophylaxis (PrEP) has demonstrated effectiveness, adherence has been low among YMSM and difficult to measure accurately. In collaboration with a healthcare company, we configured an automated directly-observed therapy (aDOT) platform for monitoring and supporting PrEP use. Based on interest expressed in focus groups among 54 YMSM, we combined aDOT with an electronic sexual diary to provide feedback on level of protection during sex and to motivate app use. In an 8-week optimization pilot with 20 YMSM in San Francisco and Atlanta, the app was found to be highly acceptable, with median System Usability Scale scores in the "excellent" range (80/100). App use was high, with median PrEP adherence of 91% based on aDOT-confirmed dosing. Most (84%) participants reported the app helped with taking PrEP. These promising findings support further evaluation of DOT Diary in future effectiveness studies.

Indexed as

HIV InfectionsMobile ApplicationsPre-Exposure ProphylaxisSexual and Gender MinoritiesArtificial IntelligenceElectronicsHomosexuality, MaleHumansMaleMedication AdherenceSan FranciscoAdherenceArtificial intelligenceHIVMobile healthPre-exposure prophylaxis

Identifiers

PMID33044687
PMCPMC7979437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.